| Long name: |
Cy5, 5 Conjugated, ADH/AVP/ARVP Polyclonal Antibody |
| Category: |
Conjugated Primary Antibodies |
| Conjugation: |
Cy5, 5, 5, Cy5 |
| Host Organism: |
Rabbit (Oryctolagus cuniculus) |
| Target Antigen: |
ADH/AVP/ARVP |
| Specificity: |
This is a highly specific antibody against ADH/AVP/ARVP |
| Modification: |
Unmodified |
| Modification site: |
None |
| Clonality: |
Polyclonal |
| Clone: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
KLH conjugated synthetic peptide derived from human ADH (CYAEDCPRG-NH2) |
| Gene ID number: |
551 |
| Tested applications: |
IF(IHC-P) |
| Recommended dilutions: |
IF(IHC-P)(1:50-200) |
| Crossreactivity: |
Human |
| Crossreactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Antigen background: |
It also plays a role in cognition, It has a direct antidiuretic action on the kidney and also causes vasoconstriction of the peripheral vessels, Mutations in the vasopressin precursor cause autosomal dominant neurohypophyseal diabetes insipidus (ADNDI), Vasopressin, Vasopressin acts as a growth factor by enhancing pH regulation through acid-base transport systems, Vasopressin can also contract smooth muscle during parturition and lactation, Vasopressin is synthesised as a precursor protein that consists of arginine vasopressin and two associated proteins, adaptation and complex sexual and maternal behaviour, also known as arginine vasopressin (AVP) or antidiuretic hormone (ADH), as well as in the regulation of water excretion and cardiovascular functions, is a posterior pituitary hormone that is synthesised in the hypothalamus, is packaged into neurosecretory vesicles and transported axonally to the nerve endings in the neurohypophysis, neurophysin 2 and the glycopeptide copeptin, polydipsia and polyuria, together with its carrier protein neurophysin II, tolerance, where it is either stored or secreted into the bloodstream, which is characterised by persistant thirst, Vasopressin |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA |
| Excitation Emission: |
675nm/694nm |
| Synonyms: |
ADH |
| Properties: |
Cy5 antibodies are excited by the 650-nanometer wave of an argon laser and detected at a 670-nanometer captor, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24° |
| Conjugated: |
These antibodies are excite for emission at 678nm and detected at a 694 , nm wavelengths |
| Gene target: |
ADH/AVP/ARVP Conjugated |
| Short name: |
Conjugated, ADH/AVP/ARVP Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody Conjugates, Antibody |
| Label: |
5, Cy5 |
| Alternative name: |
cyanine 5, 5 coupled, ADH/arginine vasopressin/ARVP (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
ADH and ARVP and AVP-NPII and AVRP and VP, AVP and IDBG-45432 and ENSG00000101200 and 551, AVP and IDBG-640134 and ENSBTAG00000008027 and 280728, Avp and IDBG-206576 and ENSMUSG00000037727 and 11998, Extracellular, cysteine-type endopeptidase inhibitor activity involved in apoptotic process, this GO :0002125 and maternal aggressive behavior and biological process this GO :0003084 and positive regulation of systemic arterial blood pressure and biological process this GO :0004672 and protein kinase activity and molecular function this GO :0004871 and signal transducer activity and molecular function this GO :0005102 and receptor binding and molecular function this GO :0005184 and neuropeptide hormone activity and molecular function this GO :0005185 and neurohypophyseal hormone activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005829 and cytosol and cellular component this GO :0006091 and generation of precursor metabolites and energy and biological process this GO :0006468 and protein phosphorylation and biological process this GO :0006833 and water transport and biological process this GO :0007165 and signal transduction and biological process this GO :0007204 and positive regulation of cytosolic calcium ion concentration and biological process this GO :0007267 and cell-cell signaling and biological process this GO :0007621 and negative regulation of female receptivity and biological process this GO :0007625 and grooming behavior and biological process this GO :0007626 and locomotory behavior and biological process this GO :0008284 and positive regulation of cell proliferation and biological process this GO :0010628 and positive regulation of gene expression and biological process this GO :0014049 and positive regulation of glutamate secretion and biological process this GO :0014070 and response to organic cyclic compound and biological process this GO :0030141 and secretory granule and cellular component this GO :0030307 and positive regulation of cell growth and biological process this GO :0030425 and dendrite and cellular component this GO :0030819 and positive regulation of cAMP biosynthetic process and biological process this GO :0031394 and positive regulation of prostaglandin biosynthetic process and biological process this GO :0031894 and V1A vasopressin receptor binding and molecular function this GO :0031895 and V1B vasopressin receptor binding and molecular function this GO :0032849 and positive regulation of cellular pH reduction and biological process this GO :0033138 and positive regulation of peptidyl-serine phosphorylation and biological process this GO :0033574 and response to testosterone and biological process this GO :0035094 and response to nicotine and biological process this GO :0035176 and social behavior and biological process this GO :0035813 and regulation of renal sodium excretion and biological process this GO :0042310 and vasoconstriction and biological process this GO :0042538 and hyperosmotic salinity response and biological process this GO :0042711 and maternal behavior and biological process this GO :0043027 and cysteine-type endopeptidase inhibitor activity involved in apoptotic process and molecular function this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0043084 and penile erection and biological process this GO :0043154 and negative regulation of cysteine-type endopeptidase activity involved in apoptotic process and biological process this GO :0043252 and sodium-independent organic anion transport and biological process this GO :0045087 and innate immune response and biological process this GO :0045471 and response to ethanol and biological process this GO :0045907 and positive regulation of vasoconstriction and biological process this GO :0050891 and multicellular organismal water homeostasis and biological process this GO :0051970 and negative regulation of transmission of nerve impulse and biological process this GO :0055085 and transmembrane transport and biological process this GO :0070371 and ERK1 and ERK2 cascade and biological process this GO :0070528 and protein kinase C signaling and biological process this GO :0090201 and negative regulation of release of cytochrome c from mitochondria and biological process, this GO :0004672 : protein kinase activity, this GO :0004672 : protein kinase activity and also this GO :0004871 : signal transducer activity and also this GO :0005102 : receptor binding and also this GO :0005184 : neuropeptide hormone activity and also this GO :0005185 : neurohypophyseal hormone activity and also this GO :0005515 : protein binding and also this GO :0031894 : V1A vasopressin receptor binding and also this GO :0031895 : V1B vasopressin receptor binding and also this GO :0043027 : cysteine-type endopeptidase inhibitor activity involved in apoptotic process, this GO :0004871 : signal transducer activity, this GO :0005102 : receptor binding, this GO :0005184 : neuropeptide hormone activity, this GO :0005185 : neurohypophyseal hormone activity, this GO :0005515 : protein binding, this GO :0031894 : V1A vasopressin receptor binding, this GO :0031895 : V1B vasopressin receptor binding, this GO :0043027 : cysteine-type endopeptidase inhibitor activity involved in apoptotic process, arginine vasopressin |
| Identity: |
894 |
| Gene: |
AVP |
More about : AVP |
| Long gene name: |
arginine vasopressin |
| Synonyms gene: |
ARVP |
| Synonyms name: |
antidiuretic hormone neurophysin II diabetes insipidus neurohypophyseal prepro-AVP-NP II prepro-arginine-vasopressin-neurophysin II copeptin |
| Locus: |
20p13 |
| Discovery year: |
1986-01-01 |
| GenBank acession: |
M25647 |
| Entrez gene record: |
551 |
| Pubmed identfication: |
1840604 |
| RefSeq identity: |
NM_000490 |
| Classification: |
Endogenous ligands |
| Havana BLAST/BLAT: |
OTTHUMG00000031733 |
| Locus Specific Databases: |
nndi LRG_715 |